Global Dermatology Partnering 2010-2016: Deal trends, players and financials

Publisher Name :
Date: 01-Nov-2016
No. of pages: 500
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

The Global Dermatology Partnering 2010-2016: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Dermatology partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Dermatology partnering agreement structure

Dermatology partnering contract documents

Top Dermatology deals by value

Most active Dermatology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2010. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Global Dermatology Partnering 2010-2016 is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.

Global Dermatology Partnering 2010-2016 includes:

Trends in dermatology dealmaking in the biopharma industry since 2010

Analysis of dermatology deal structure

Access to headline, upfront, milestone and royalty data

Access to over 700 dermatology deal records

The leading dermatology deals by value since 2010

The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2010-2016, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Dermatology Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 650 dermatology deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Dermatology Partnering 2010 to 2016 provides the reader with the following key benefits:

In-depth understanding of dental deal trends since 2010

Access dermatology deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between dermatology partner companies

Comprehensive access to over 750 links to actual dermatology deals entered into by the world's biopharma companies

Indepth review of dermatology deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner dermatology opportunities

Uncover companies actively partnering dermatology opportunities

Global Dermatology Partnering 2010-2016: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Dermatology dealmaking
2.1. Introduction
2.2. Dermatology partnering over the years
2.3. Dermatology partnering by deal type
2.4. Dermatology partnering by industry sector
2.5. Dermatology partnering by stage of development
2.6. Dermatology partnering by technology type
2.7. Dermatology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Dermatology partnering
3.1. Introduction
3.2. Disclosed financials terms for Dermatology partnering
3.3. Dermatology partnering headline values
3.4. Dermatology deal upfront payments
3.5. Dermatology deal milestone payments
3.6. Dermatology royalty rates

Chapter 4 - Leading Dermatology deals and dealmakers
4.1. Introduction
4.2. Most active in Dermatology partnering
4.3. List of most active dealmakers in Dermatology
4.4. Top Dermatology deals by value

Chapter 5 - Dermatology contract document directory
5.1. Introduction
5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Dermatology therapeutic target

Appendices
Appendix 1 - Directory of Dermatology deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Dermatology deals by deal type 2010 to 2016
Appendix 3 - Directory of Dermatology deals by stage of development 2010 to 2016
Appendix 4 - Directory of Dermatology deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Tables and Figures

Figure 1: Dermatology partnering since 2010
Figure 2: Dermatology partnering by deal type since 2010
Figure 3: Dermatology partnering by industry sector since 2010
Figure 4: Dermatology partnering by stage of development since 2010
Figure 5: Dermatology partnering by technology type since 2010
Figure 6: Dermatology partnering by indication since 2010
Figure 7: Dermatology deals with a headline value
Figure 8: Dermatology deals with upfront payment values
Figure 9: Dermatology deals with milestone payment
Figure 10: Dermatology deals with royalty rates
Figure 11: Active Dermatology dealmaking activity- 2010 to 2016
Figure 12: Top Dermatology deals by value since 2010
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Efficacy of Stand-alone Power Sources Drive The Global Distributed Energy Generation Market
    The global market for distributed energy generation is expected to magnify at a momentous CAGR of 11.4% between 2016 and 2020. The small-scale generation of electricity, oscillating from a few kilowatts to multitudes of megawatts, is denoted as distributed energy generation. In this process, power is usually produced using renewable resources or by generators during consumption. [...]
  • Global Organic Food Market Makes A Mark in Developed Economies
    Buyers throughout the world are becoming more and more health cognizant, which has occasioned in an alteration in their palates and inclinations. The global organic food market was worth US$88.1 billion in 2015 is anticipated to record a CAGR of over 16% between 2015 and 2020. Amongst the various different food products available, the fruits [...]
  • Global Tretinoin Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 17-Jan-2017        Price: US 3480 Onwards        Pages: 117
    Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to treat acne vulgaris. It is also used orally to treat acute promyelocytic leukemia (APL). Its isomer, isotretinoin, is also an acne drug. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications neede......
  • Anti Dermatomycosis Skin Drugs Markets in China
    Published: 15-Jan-2017        Price: US 4000 Onwards        Pages: 221
    China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry ca......
  • Anti Dermatomycosis Skin Drugs Companies in China
    Published: 15-Jan-2017        Price: US 1800 Onwards        Pages: 71
    This study focuses on China's Anti Dermatomycosis Skin Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the c......
  • Anti Dermatomycosis Skin Drugs Industry Forecasts - China Focus
    Published: 15-Jan-2017        Price: US 1800 Onwards        Pages: 100
    This study focuses on China's Anti Dermatomycosis Skin Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods an......
  • United States Hyaluronic Acid Based Dermal Fillers Market Report 2017
    Published: 10-Jan-2017        Price: US 3800 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Hyaluronic Acid Based Dermal Fillers Revenue, means the sales value of Hyaluronic Acid Based Dermal Fillers This report studies sales (consumption) of Hyaluronic Acid Based Dermal Fillers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Galderma - Allergan - Sanofi - Merz - LG Life Sciences - Sinclair - T......
  • Global Dermatology Drug Market Professional Survey Report 2017
    Published: 09-Jan-2017        Price: US 3500 Onwards        Pages: 120
    Notes: Production, means the output of Dermatology Drug Revenue, means the sales value of Dermatology Drug This report studies Dermatology Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market......
  • Global Acne Drugs Market Research Report 2017
    Published: 06-Jan-2017        Price: US 2900 Onwards        Pages: 127
    Notes: Production, means the output of Acne Drugs Revenue, means the sales value of Acne Drugs This report studies Acne Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Belli - Kate Somerville - Doudou Kang - Pikangwang - Cetaphil - Diff......
  • Global Hyaluronic Acid Based Dermal Fillers Market Professional Survey Report 2017
    Published: 05-Jan-2017        Price: US 3500 Onwards        Pages: 121
    Notes: Production, means the output of Hyaluronic Acid Based Dermal Fillers Revenue, means the sales value of Hyaluronic Acid Based Dermal Fillers This report studies Hyaluronic Acid Based Dermal Fillers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers ......
  • United States Dermatology Drug Market Report 2017
    Published: 03-Jan-2017        Price: US 3800 Onwards        Pages: 97
    Notes: Sales, means the sales volume of Dermatology Drug Revenue, means the sales value of Dermatology Drug This report studies sales (consumption) of Dermatology Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Rishiroop Group - Bech Chem - Ruize Chemical - Shandong Tianchen Chemical - Fujian Wantaixing Chemical Development - Fenghua YURON Chemi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs